RT @jljcolorado: @Piruletadementa Me refiero a este estudio: https://t.co/XmbXOP3xtr
RT @jljcolorado: @Piruletadementa Me refiero a este estudio: https://t.co/XmbXOP3xtr
@Piruletadementa Me refiero a este estudio: https://t.co/XmbXOP3xtr
@michael_b28 @IKGB10 @JesseVentura86 @Floudl @DerNiederbayer Ich hab auf die Schnelle was vom CDC gefunden. Moderna überlegen. https://t.co/ooylPXj3eg https://t.co/ArmeHvvWxg
@KNG94Rich @MomFluffyz @Morvern_C_ @paulcwhite Moderna has the highest efficacy than Pfizer or J&J at 93%. But pretty good rolling out during a pandemic. https://t.co/U6XocGOgve
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) #vaccines in Preventing #COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 | MMWR #Vaccin https://t.co
@F0410D @RogerRa27019335 @ZipiZapismo No había leído estupidez más grande que justificar el dopaje y no las vacunas. Le comparto evidencia científica que contradice todo lo que usted está diciendo (hay otras mil), tanto en vacunas como en dopaje https://t
@ShayneWissler @ben_r_hoffman The main source is a CDC study https://t.co/7KwCD62z5N I realize the CDC lies but I'm too lazy to look up a better source and I don't think it would change the numbers much
@SportsTalkJMN @embarly123 @gp1980cos @indy100 https://t.co/uxyPA15oF2 Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%
@DaveAtherton20 @domjoly @NHS @sajidjavid They are almost exactly the same, but Moderna has a higher mRNA dose and better mixing/formulation (higher stability) - so has been found to have better protection than Pfizer (and slightly more side-effects) https
@Btctsla1 @DlouheB @DolezalSr Tady jsou oficiální data z amerických testů: https://t.co/U0X7BDm9A1 - zajímá vás asi řádek "COVID-19 case" v té tabulce. I v počtu nakažení je významný pokles.
@elgatomimo @RupieltoRupelto @jose4ez Vale. Comenta pues: https://t.co/qktSJmDRAM
@RoeptU @Tineke44576991 @makschaap73 @RTLnieuws https://t.co/lnpZdOjriQ en ga zo maar door. Maar jij zult toch je eigen subjectieve observatie waardevoller vinden dan echt wetenschappelijk onderzoek
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
@Cryptobert12 Er zijn wel meer studies, dit is idd nog pre-print. CDC heeft het over factor 8 voor ziekenhuis: https://t.co/pErBMAJw4m, voor 12-18 jaar is het ongeveer 15.
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
Con las vacunas de adenovectores (Janssen y también Astra-Zeneca) frente para la #COVID19 se observa una disminución marcadamente más rápida de los anticuerpos anti-Spike al compararla con vacunas mRNA (Moderna o Pfizer).
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @ckwadrat: AZ i JJ dwa rzędy wielkości różnicy in minus w przeciwciałach w stosunku do mRNA -- kolejne potwierdzenie, że to kiepskie szc…
AZ i JJ dwa rzędy wielkości różnicy in minus w przeciwciałach w stosunku do mRNA -- kolejne potwierdzenie, że to kiepskie szczepionki. Brać po nich dodatkową/przypominającą dawkę as soon as possibile!
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
note the log scale!
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
Results obviously show Moderna's & Pfizer's mRNA vaccines are more effective. The fact remains, all 4 vaccines have same major limitation. Decline of anti-spike antibodies 4-6mo. None of the 4 vaccines by itself is going to stop covid-19 infections. Re
RT @CUEmergency: A new #publication by @AditGinde et al explores #vaccine effectiveness against #COVID-19 hospitalization among US adults w…
Comparative Effectiveness of Moderna... https://t.co/ENkOwsOiRe vía @CDCgov
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @cgonzagaj: Interesting and possibly relevant too for those vaccinated with other Adenovector-based vaccines like millions of teachers v…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
Interesting and possibly relevant too for those vaccinated with other Adenovector-based vaccines like millions of teachers vaccinated with Cansino in Mexico 🇲🇽
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
RT @EricTopol: The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for…
The rapid and marked decline of anti-Spike antibodies seen with the AZ vaccine is very similar to what has been reported for the J&J (both adenovector-based) https://t.co/kvBoSzBkBd @CDCMMWR https://t.co/k2SbEmlZCd
@StimmederVernu9 @Julia_C_Koch @lehr_thorsten Juhu, was qualitatives 👍. Richtig, BioNTech lässt wohl stärker nach als Moderna. Auch das CDC hat hier ne Studie dazu veröffentlicht. https://t.co/BW4y2IdVY7 Die Wissenschaftler zum Ergebnis, alle drei Impfstof
A new #publication by @AditGinde et al explores #vaccine effectiveness against #COVID-19 hospitalization among US adults without immunocompromising conditions https://t.co/sD7bTcjaXm From: @CDCgov MMWR #MedTwitter | #COVID | #vaccinated https://t.co/0i
@PPPVacek @HuJirui "VE for the Pfizer-BioNTech vaccine was 91% at 14–120 days (median = 69 days) after receipt of the second vaccine dose but declined significantly to 77% at >120 days (median = 143 days) (p<0.001)." https://t.co/BPELx8Ihe6
RT @Ferhatarslandr: Diyelim ki bağışıklık sisteminiz normal ama erişkin ve Risk grubunda bir hastasınız Örneğin diyabet, kalp hastalığınız…
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing #COVID19 Hospitalizations Among Adults Without Immunocompromising Conditions https://t.co/N5VnYJkdDY #precisionEM @CDCgov @jennygwilson ht
RT @Ferhatarslandr: Diyelim ki bağışıklık sisteminiz normal ama erişkin ve Risk grubunda bir hastasınız Örneğin diyabet, kalp hastalığınız…
RT @Ferhatarslandr: Diyelim ki bağışıklık sisteminiz normal ama erişkin ve Risk grubunda bir hastasınız Örneğin diyabet, kalp hastalığınız…
Diyelim ki bağışıklık sisteminiz normal ama erişkin ve Risk grubunda bir hastasınız Örneğin diyabet, kalp hastalığınız ve kronik akciğer sorununuz var Aşısızlara oranla ciddi oranda hastaneye yatışınız neden artar? Tablo 1 inceleyin https://t.co/3oZf8RsLC
@ComoAustralia 表面的なデータでもCDC集計の治験者の半分がBMIで肥満、25%が糖尿病、何かしらの高リスク要素持ちが6割の人を摂取者と非接種に分けてテストされてもな〜と。そりゃ非接種者やばいやろねと。 https://t.co/ML9ALHYJ1f https://t.co/KAmtZDAuyD
@ZoeMcLaren 1/3 failure rate for hospitalization, when avoidable, seems reckless to continue to deploy. Recommendation for all to get a booster doesn't make sense going forward. If all need a booster, then just give all a two dose series. https://t.co/jZ2
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
@hugodejonge Source o.a https://t.co/LSBmYmELBK & https://t.co/fuuRfcaCco
@roopstar21 @WSJ You can absolutely still get sick, particularly Pfizer or J&J without a booster. Risk even of hospitalization reduced 2x or 3x, but still very much there. https://t.co/jZ23R5SMV1 https://t.co/RyqgsoyCeV
@AgingAnarchist CDCのレポートの治験参加者の半分が肥満で笑ってしまいましたわ😂 持病持ち6割超えじゃそりゃコロナであんなに亡くなる訳だ… https://t.co/ML9ALHYJ1f https://t.co/jkdvg8gUEW
RT @mindgomes: How can any study predict “preventing hospitalization”? https://t.co/9WrUkyZuv2 @sanchak74
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
How can any study predict “preventing hospitalization”? https://t.co/9WrUkyZuv2 @sanchak74
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
RT @suzuki_takaya: ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA…
ファイザーとモデルナの比較ですが、モデルナの「方がすこし良い」みたいなデータが存在しないわけではありません。というかまあまああって、実際にそうなんだと思います。ただこれがワクチンの「性能」によるものなのかというと、そもそもドース内のmRNA量がモデルナは3.3倍 https://t.co/RX044ZrkvU
@breckgirl4ever Depends on your metrics. Vaccines have to have an efficacy of 50% to be approved, which this does. The efficacy for hospitalization is 88-93%. https://t.co/iskzhNLvQM
@DerkaSoup @GraemeAmbrose @elcritico_loco @VaushV @JonTronShow Headlines on a news outlet does not truth make. https://t.co/NAaLZHHApX https://t.co/fvTUNTNd5K https://t.co/1iucv0oKUL Data shows the vaccines still remain significantly (80%-95%) effective